<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Mattos Barbosa MG</submitter><funding>NIBIB NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIH Office of the Director</funding><pagination>150483</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8492324</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(17)</volume><pubmed_abstract>Host genes define the severity of inflammation and immunity but specific loci doing so are unknown. Here we show that TNF receptor superfamily member 13B (TNFRSF13B) variants, which enhance defense against certain pathogens, also control immune-mediated injury of transplants, by regulating innate B cells' functions. Analysis of TNFRSF13B in human kidney transplant recipients revealed that 33% of those with antibody-mediated rejection (AMR) but fewer than 6% of those with stable graft function had TNFRSF13B missense mutations. To explore mechanisms underlying aggressive immune responses, we investigated alloimmunity and rejection in mice. Cardiac allografts in Tnfrsf13b-mutant mice underwent early and severe AMR. The dominance and precocity of AMR in Tnfrsf13b-deficient mice were not caused</pubmed_abstract><journal>JCI insight</journal><pubmed_title>TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.</pubmed_title><pmcid>PMC8492324</pmcid><funding_grant_id>EB 022033</funding_grant_id><funding_grant_id>R56 AI123262</funding_grant_id><funding_grant_id>AI122369</funding_grant_id><funding_grant_id>R01 AI122369</funding_grant_id><funding_grant_id>R01 EB022033</funding_grant_id><funding_grant_id>R21 AI159219</funding_grant_id><funding_grant_id>R01 AI151588</funding_grant_id><funding_grant_id>R21 AI117561</funding_grant_id><funding_grant_id>R01 AI139633</funding_grant_id><funding_grant_id>AI 151588</funding_grant_id><funding_grant_id>AI117561</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Platt JL</pubmed_authors><pubmed_authors>Barnes J</pubmed_authors><pubmed_authors>de Mattos Barbosa MG</pubmed_authors><pubmed_authors>Huynh D</pubmed_authors><pubmed_authors>Fu B</pubmed_authors><pubmed_authors>Bram RJ</pubmed_authors><pubmed_authors>Geha RS</pubmed_authors><pubmed_authors>Cascalho M</pubmed_authors><pubmed_authors>Samaniego M</pubmed_authors><pubmed_authors>Prak ETL</pubmed_authors><pubmed_authors>Farkash EA</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Shikanov A</pubmed_authors><pubmed_authors>Lefferts AR</pubmed_authors></additional><is_claimable>false</is_claimable><name>TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.</name><description>Host genes define the severity of inflammation and immunity but specific loci doing so are unknown. Here we show that TNF receptor superfamily member 13B (TNFRSF13B) variants, which enhance defense against certain pathogens, also control immune-mediated injury of transplants, by regulating innate B cells' functions. Analysis of TNFRSF13B in human kidney transplant recipients revealed that 33% of those with antibody-mediated rejection (AMR) but fewer than 6% of those with stable graft function had TNFRSF13B missense mutations. To explore mechanisms underlying aggressive immune responses, we investigated alloimmunity and rejection in mice. Cardiac allografts in Tnfrsf13b-mutant mice underwent early and severe AMR. The dominance and precocity of AMR in Tnfrsf13b-deficient mice were not caused</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T10:33:26.49Z</modification><creation>2022-02-11T11:58:01.695Z</creation></dates><accession>S-EPMC8492324</accession><cross_references><pubmed>34283811</pubmed><doi>10.1172/jci.insight.150483</doi></cross_references></HashMap>